文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

全脑放射治疗同步整合增敏期间优化海马 sparing 及完全定向海马 block 的疗效。

Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost-tutorial and efficacy of complete directional hippocampal blocking.

机构信息

Department of Radiation Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Robert-Koch Str. 3, 79106, Freiburg, Germany.

German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.

出版信息

Strahlenther Onkol. 2022 Jun;198(6):537-546. doi: 10.1007/s00066-022-01916-3. Epub 2022 Mar 31.


DOI:10.1007/s00066-022-01916-3
PMID:35357511
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9165264/
Abstract

PURPOSE: Hippocampus-avoidance whole brain radiotherapy with simultaneous integrated boost (HA-WBRT+SIB) is a complex treatment option for patients with multiple brain metastases, aiming to prevent neurocognitive decline and simultaneously increase tumor control. Achieving efficient hippocampal dose reduction in this context can be challenging. The aim of the current study is to present and analyze the efficacy of complete directional hippocampal blocking in reducing the hippocampal dose during HA-WBRT+SIB. METHODS: A total of 30 patients with multiple metastases having undergone HA-WBRT+SIB were identified. The prescribed dose was 30 Gy in 12 fractions to the whole brain, with 98% of the hippocampus receiving ≤ 9 Gy and 2% ≤ 17 Gy and with SIB to metastases/resection cavities of 36-51 Gy in 12 fractions. Alternative treatment plans were calculated using complete directional hippocampal blocking and compared to conventional plans regarding target coverage, homogeneity, conformity, dose to hippocampi and organs at risk. RESULTS: All alternative plans reached prescription doses. Hippocampal blocking enabled more successful sparing of the hippocampus, with a mean dose of 8.79 ± 0.99 Gy compared to 10.07 ± 0.96 Gy in 12 fractions with the conventional method (p < 0.0001). The mean dose to the whole brain (excluding metastases and hippocampal avoidance region) was 30.52 ± 0.80 Gy with conventional planning and 30.28 ± 0.11 Gy with hippocampal blocking (p = 0.11). Target coverage, conformity and homogeneity indices for whole brain and metastases, as well as doses to organs at risk were similar between planning methods (p > 0.003). CONCLUSION: Complete directional hippocampal blocking is an efficient method for achieving improved hippocampal sparing during HA-WBRT+SIB.

摘要

目的:海马回避全脑放疗联合同步整合推量(HA-WBRT+SIB)是一种治疗多发脑转移瘤的复杂治疗方案,旨在预防神经认知功能下降的同时提高肿瘤控制率。在这种情况下,实现高效的海马剂量减少是具有挑战性的。本研究的目的是介绍并分析在 HA-WBRT+SIB 中完全定向性海马阻断降低海马剂量的疗效。

方法:共纳入 30 例接受 HA-WBRT+SIB 治疗的多发脑转移瘤患者。全脑处方剂量为 30Gy/12f,98%的海马接受剂量≤9Gy,2%的海马接受剂量≤17Gy,转移瘤/切除腔 SIB 剂量为 36-51Gy/12f。计算并比较了采用完全定向性海马阻断的替代治疗计划与常规计划在靶区覆盖、均匀性、适形性、海马剂量和危及器官剂量方面的差异。

结果:所有替代计划均达到了处方剂量。海马阻断能更成功地保护海马,12 分次时,阻断组的平均海马剂量为 8.79±0.99Gy,而常规组为 10.07±0.96Gy(p<0.0001)。全脑(不包括转移瘤和海马回避区)的平均剂量,常规组为 30.52±0.80Gy,阻断组为 30.28±0.11Gy(p=0.11)。两种计划方法的全脑和转移瘤靶区覆盖、适形性和均匀性指数以及危及器官剂量相似(p>0.003)。

结论:完全定向性海马阻断是一种在 HA-WBRT+SIB 中实现更好的海马保护的有效方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e677/9165264/81f1604fc8df/66_2022_1916_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e677/9165264/0c12677ebf11/66_2022_1916_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e677/9165264/e61fd84903eb/66_2022_1916_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e677/9165264/81f1604fc8df/66_2022_1916_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e677/9165264/0c12677ebf11/66_2022_1916_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e677/9165264/e61fd84903eb/66_2022_1916_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e677/9165264/81f1604fc8df/66_2022_1916_Fig3_HTML.jpg

相似文献

[1]
Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost-tutorial and efficacy of complete directional hippocampal blocking.

Strahlenther Onkol. 2022-6

[2]
Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.

Med Dosim. 2016

[3]
Potential for reduced radiation-induced toxicity using intensity-modulated arc therapy for whole-brain radiotherapy with hippocampal sparing.

J Appl Clin Med Phys. 2015-9-8

[4]
Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG).

BMC Cancer. 2020-6-8

[5]
Dosimetric comparison between RapidArc and HyperArc in hippocampal-sparing whole-brain radiotherapy with a simultaneous integrated boost.

Med Dosim.

[6]
Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study.

BMC Cancer. 2020-6-30

[7]
Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: a planning study on treatment concepts.

Int J Radiat Oncol Biol Phys. 2012-4-18

[8]
Hippocampal Sparing Whole Brain Radiotherapy and Integrated Simultaneous Boost vs Stereotactic Radiosurgery Boost: A Comparative Dosimetric Planning Study.

Asian Pac J Cancer Prev. 2016

[9]
Randomised prospective phase II trial in multiple brain metastases comparing outcomes between hippocampal avoidance whole brain radiotherapy with or without simultaneous integrated boost: HA-SIB-WBRT study protocol.

BMC Cancer. 2020-10-30

[10]
Assessment of multi-criteria optimization (MCO) for volumetric modulated arc therapy (VMAT) in hippocampal avoidance whole brain radiation therapy (HA-WBRT).

J Appl Clin Med Phys. 2018-2-7

引用本文的文献

[1]
Intensity-modulated proton therapy for hippocampal-sparing prophylactic cranial irradiation: a planning comparison with photon therapy.

BMC Cancer. 2025-4-8

[2]
A dosimetric comparison of non-coplanar volumetric modulated arc therapy and non-coplanar fixed field intensity modulated radiation therapy in hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for brain metastases.

Front Oncol. 2025-1-23

[3]
Outcome of whole brain irradiation with a dose-escalated simultaneous-integrated boost in patients with multiple large and/or diffuse brain metastases: real live data and review of the literature.

Discov Oncol. 2024-8-7

[4]
Neuroprotection in radiotherapy of brain metastases: A pattern-of-care analysis in Germany, Austria and Switzerland by the German Society for radiation Oncology - working group Neuro-Radio-Oncology (DEGRO AG-NRO).

Clin Transl Radiat Oncol. 2024-4-20

[5]
Hippocampus substructure segmentation using morphological vision transformer learning.

Phys Med Biol. 2023-12-1

[6]
Treatment of Central Nervous System Tumors on Combination MR-Linear Accelerators: Review of Current Practice and Future Directions.

Cancers (Basel). 2023-10-29

[7]
The First Survival Score for Patients Treated with Whole-Brain Radiotherapy Plus Simultaneous Integrated Boost for Brain Metastases.

Biology (Basel). 2023-4-12

[8]
Treatment plan comparison for irradiation of multiple brain metastases with hippocampal avoidance whole brain radiotherapy and simultaneous integrated boost using the Varian Halcyon and the Elekta Synergy platforms.

Radiat Oncol. 2022-11-21

[9]
Radiation Exposure of Crystalline Bodies during Interventional Therapy and Related Research Status.

Contrast Media Mol Imaging. 2022

本文引用的文献

[1]
Association Between Brain Substructure Dose and Cognitive Outcomes in Children With Medulloblastoma Treated on SJMB03: A Step Toward Substructure-Informed Planning.

J Clin Oncol. 2022-1-1

[2]
Hippocampus-Avoidance Whole-Brain Radiation Therapy Is Efficient in the Long-Term Preservation of Hippocampal Volume.

Front Oncol. 2021-8-19

[3]
Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG).

BMC Cancer. 2020-6-8

[4]
Magnetic resonance imaging for brain stereotactic radiotherapy : A review of requirements and pitfalls.

Strahlenther Onkol. 2020-3-23

[5]
Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases.

Cancer. 2020-6-1

[6]
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.

J Clin Oncol. 2020-4-1

[7]
Helical tomotherapy with a complete-directional-complete block technique effectively reduces cardiac and lung dose for left-sided breast cancer.

Br J Radiol. 2020-1-21

[8]
Quality of life in patients with limited (1-3) brain metastases undergoing stereotactic or whole brain radiotherapy : A prospective study of the DEGRO QoL working group.

Strahlenther Onkol. 2019-8-15

[9]
Distribution of metastasis in the brain in relation to the hippocampus: a retrospective single-center analysis of 565 metastases in 116 patients.

Cancer Imaging. 2019-1-22

[10]
Efficacy of virtual block objects in reducing the lung dose in helical tomotherapy planning for cervical oesophageal cancer: a planning study.

Radiat Oncol. 2018-4-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索